Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, Alembic Pharmaceuticals has informed that it has enclosed the Annual Secretarial Compliance Report issued by Samdani Shah & Kabra, Practicing Company Secretaries, for the financial year ended 31st March, 2021.
The above information is a part of company’s filings submitted to BSE.